Andreas Rybka

Q: What is Andreas Rybka email address?

Email Andreas Rybka at arybka@web.de and andreas.rybka@boehringer-ingelheim.com. This email is the most updated Andreas Rybka's email found in 2026.

Q: How to contact Andreas Rybka?

To contact Andreas Rybka send an email to arybka@web.de or andreas.rybka@boehringer-ingelheim.com. (updated on March 24, 2025)

Senior Manager External Analytics at Boehringer Ingelheim | Germany

About Andreas Rybka

Andreas Rybka currently serves as Senior Manager of External Analytics at Boehringer Ingelheim, where he plays a pivotal role in advancing the company's peptide and biologics portfolio through innovative analytical strategies. In this capacity, Andreas leads collaborative efforts with external partners, including contract research organizations and academic institutions, to develop and validate cutting-edge analytical methods that ensure the quality, safety, and efficacy of peptide-based NCEs (New Chemical Entities). His expertise in biophysical characterization techniques such as Static Light Scattering and advanced chromatography methods like HPLC and LC-MS enables the team to thoroughly assess the structural integrity, purity, and stability of biologics across various application routes.

A key focus of Andreas’s work involves translating complex analytical data into actionable insights that support formulation development, process optimization, and regulatory submissions. His deep understanding of protein chemistry, proteomics, and solid-phase synthesis allows him to troubleshoot challenges in peptide synthesis and characterization, ensuring seamless technology transfer from development to manufacturing. Andreas’s innovative approach combines analytical chemistry, biotechnology, and regulatory knowledge—often employing "analytical magic"—to turn scientific challenges into opportunities for market-ready biologics.

With over two decades of experience in peptide and protein chemistry, Andreas is recognized for his flexibility and out-of-the-box thinking, which foster collaborative problem-solving and continuous improvement. His role at Boehringer Ingelheim exemplifies his commitment to leveraging analytical excellence to accelerate biologics development, ultimately contributing to the company’s mission of delivering impactful therapies to patients worldwide.

Andreas Rybka Work